VERTEX PHARMACEUTICALS INC / MA Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Vertex Pharmaceuticals Inc / Ma Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $1.05B, a 0.98% increase year-over-year.
  • Vertex Pharmaceuticals Inc / Ma Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$480M, a 114% decline year-over-year.
  • Vertex Pharmaceuticals Inc / Ma annual Net Income (Loss) Attributable to Parent for 2023 was $3.62B, a 8.96% increase from 2022.
  • Vertex Pharmaceuticals Inc / Ma annual Net Income (Loss) Attributable to Parent for 2022 was $3.32B, a 41.8% increase from 2021.
  • Vertex Pharmaceuticals Inc / Ma annual Net Income (Loss) Attributable to Parent for 2021 was $2.34B, a 13.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.62B +$298M +8.96% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $3.32B +$980M +41.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $2.34B -$370M -13.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $2.71B +$1.53B +130% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 $1.18B -$920M -43.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 $2.1B +$1.83B +696% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $263M +$376M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 -$112M +$444M +79.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-13
2015 -$556M +$182M +24.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 -$739M -$294M -66% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 -$445M -$338M -316% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-16
2012 -$107M -$137M -462% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 $29.6M +$784M Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
2010 -$755M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.